Author:
Shah Nina,Mustafa S. Shahzad,Vinh Donald C.
Reference111 articles.
1. Asia Pacific Immunoglobulins in Immunology Expert Group (APIIEG). 2009. Consensus recommendations for the use of immunoglobulin replacement therapy in immune deficiency.
2. Association of immunoglobulin levels, infectious risk, and mortality with rituximab and hypogammaglobulinemia;Barmettler;JAMA Netw. Open,2018
3. C.S.L. Behring, 2022. Summary of product characteristics (Hizentra). [Available from: 〈https://www.ema.europa.eu/en/documents/product-information/hizentra-epar-product-information_en.pdf〉 [Accessed 24 January 2022].
4. The use of Octagam and Gammanorm in immunodeficiency associated with hematological malignancies: a prospective study from 21 French hematology departments;Benbrahim;Hematology,2019
5. Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy;Bhoj;Blood,2016
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献